Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SZSE:002940) signed a share transfer agreement to acquire an additional 38.22% stake in Hunan Kerey Pharmaceutical Co., Ltd. from Gan Hongxing, Hu Aiguo, Yang Xiangxin and Xie Laibin for approximately CNY 191.3 million on October 10, 2022. Total number of shares to be acquired is 27.3 million. Post acquisition, Gan Hongxing will hold 5.04% stake, Zhejiang AngLiKang Pharmaceutical CO.,LTD. will hold 61.70% stake, Hu Aiguo will hold 2.62% stake, Yang Xiangxin will hold 2.49% stake, Zhu Qi will hold 4.83% stake, Wu Yongde will hold 4.39% stake, Gao Qiang will hold 4.29% stake, Xie Laibin will hold 1.92% stake,Wu Yucheng will hold 2.54% stake and Xiao Li will hold 1.49% stake in unan Kerey Pharmaceutical.

The earlier agreement to acquire 61% stake has been terminated. The transaction has been approved by Board of directors of Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SZSE:002940) on October 10, 2022.